Resectie van levermetastasen bij borstkanker: Stand van zaken

Abstract

Liver metastases have the poorest prognosis of all types of breast cancer metastases, with a 5year survival rate of 0 to 12%. In comparison, the 5year overall survival rate of patients with colorectal liver metastases undergoing curative liver resection is approximately 30 to 40% and even 50% in selected patients. Partial liver resection in combination with systemic treatment for patients with hepatogenic metastases from breast cancer may lead to improved survival rates for selected patients.